Quest and LabCorp
Connectivity to national lab networks for current-state biomarker panels.
Platform
Six owned layers under your brand: blood labs, genetic reports, telehealth, a 503A prescribing pathway, a supplement line and a branded patient app — with an independent provider network licensed in all 50 states behind every clinical decision.
Connectivity to national lab networks for current-state biomarker panels.
Panels pass through at wholesale; you set retail and keep the margin on labs.
Results land in the branded patient app as part of a unified health record.
Genetic pathway reports produced through CLIA-certified labs.
Reports map variants to pathways as an educational roadmap, not a diagnosis or prescription.
The report is presented under your brand inside the patient app.
Phone and video consults with the independent, board-certified network licensed in all 50 states.
Consults pass through at a wholesale base; you set your retail upcharge and keep the margin.
Visits run on HIPAA-compliant infrastructure; you never touch protected health information.
A prescribing capability owned entirely by the independent, board-certified network; you never prescribe.
Compounded preparations available through a 503A-capable pathway, by category, where the network deems appropriate.
Every clinical and prescribing decision rests with the licensed providers, not with you or Wellstaq.
A supplement line presented entirely under your name.
Products arrive at wholesale; you set retail and keep the margin on supplements.
Patients reorder directly through the branded app for recurring revenue.
Labs, genetic reports, telehealth, refills, and supplements in one app under your brand.
Blood and genetic data sit together in a longitudinal patient view.
You manage the experience while the independent network manages clinical care.
How the economics work
$2,000/mo flat platform fee — the only cut we take. Blood labs, telehealth and supplements pass through at true wholesale cost; you set retail and keep the margin. Wellstaq takes 0% of your sales.
The independent, board-certified provider network, licensed in all 50 states, owns all clinical and prescribing decisions. You and Wellstaq never prescribe and never touch protected health information.
A flat $2,000/mo for platform access. Goods and services pass through at wholesale; you set retail on labs, telehealth, and supplements, and Wellstaq takes 0% of your sales.
A flat $2,000/mo, wholesale pass-through, and 0% of your sales. Get on the list before spots open.
Wellstaq provides technology and brand infrastructure. All clinical decisions, evaluations and prescribing are made by an independent, board-certified provider network licensed in all 50 states. Wellstaq and its partners make no diagnosis, treatment, efficacy or outcome claims; nothing here is medical advice.